Apogee Therapeutics, Inc. (DELISTED) (APGE:DL)
135.07
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
Apogee Therapeutics EPS Diluted (Quarterly) : -1.138 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.138 |
| March 31, 2026 | -1.064 |
| December 31, 2025 | -1.026 |
| September 30, 2025 | -1.106 |
| June 30, 2025 | -1.131 |
| March 31, 2025 | -0.9509 |
| December 31, 2024 | -1.130 |
| September 30, 2024 | -0.8631 |
| June 30, 2024 | -0.5984 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.6394 |
| December 31, 2023 | -0.6265 |
| September 30, 2023 | -0.4112 |
| June 30, 2023 | -0.3727 |
| March 31, 2023 | -0.2472 |
| December 31, 2022 | -0.2764 |
| September 30, 2022 | -0.3879 |
| June 30, 2022 | -0.0358 |
| March 31, 2022 | -0.085 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Intellia Therapeutics, Inc. | -0.7989 |
| Cogent Biosciences, Inc. | -0.5636 |
| Revolution Medicines, Inc. | -3.055 |
| Moderna, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -85.85M |
| Total Expenses (Quarterly) | 85.85M |
| Enterprise Value | 9.310B |
| Earnings Yield | -3.21% |
| Normalized Earnings Yield | -3.179 |